Some studies examining clinical tissues have also revealed that high expression levels of glutathione S-transferase (the enzyme that assists CDDP with GSH conjugation) and MT are associated with reduced CDDP efficacy in patients with lung, ovarian, and esophageal cancer [35,37]. The gene discussed is HPGDS; the disease is esophageal cancer.